NEWS VIDEO + ARTICLE: IBM and Pfizer are joining forces to innovate exciting hi-tech care solutions for people with brain disease. The experiment will use
VIDEO + ARTICLE: In an effort to educate potential volunteers to try RVT-101 in a clinical trial, the MINDSET STUDY is trying something new. Doctors
Can a flickering light predict dementia, diagnose it and measure its progress? University of Georgia researchers think it can. Patients watch a flickering light that
Axovant launches nelotanserin and 3 new clinical programs to treat Lewy body dementia. Also, their drug RVT-101 for Dementia with Lewy Bodies and Alzheimer’s gets
Diagnosing Alzheimer’s just took a giant step forward. Swedish researchers have published a new, internationally recognized method to measure the main protein that causes it.
SEMINAR OF THE WEEK: See how exciting research is opening new windows to accurate, early diagnosis of Alzheimer’s. Learn how this is bringing hope for
Scientists now have a gene variant that seems to push off Alzheimer’s by 10 years. Learn how they want to use the way it works
Many clinical trials for new Alzheimer’s drugs try to clear plaque on the brain. The toxic plaques are made of amyloid-beta. Researchers recently discovered another
VIDEO + ARTICLE: New research puts prions in the dementia/depression spotlight. What are they? Can the role prions play explain the depressive-like behavior common in
CBS VIDEO + ARTICLE: Excitement and Hope are 2 words not often heard in Alzheimer’s clinical trials, but new results for solanezumab are generating quite
See why Leqembi is even more effective in males than females, at fighting Alzheimer’s.
Stanford Medicine’s new analysis of a vaccination program found shingles vaccines appear to lower dementia diagnoses by 20% — more than any other known intervention.
The big Alzheimer’s culprits are Amyloid and Tau. Biogen made Leqembi to treat amyloid. Now, they are betting on BIIB080 to treat tau. Learn how this exciting new treatment just got FDA Fast Track Designation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor